Skip to main content

MoneyWorks4Me

Orchid Pharma informs about investor roadshow

04 Jun 2024 Evaluate
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Orchid Pharma has informed that Mridul Dhanuka, Whole Time Director of Orchid Pharma (the Company) will be participating in Roadshows scheduled to be held as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..